Journal Information
Case and Research Letter
Full text access
Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial
Efectividad y seguridad a medio plazo de upadacitinib en adolescentes con dermatitis atópica moderada a grave: un estudio multicéntrico en práctica clínica (34 pacientes)
F.J. Melgosa-Ramosa,
Corresponding author
javimelgo2017@gmail.com

Corresponding author.
, A. Vicente Villab, I. Betlloch Masc, S. Santos-Alarcónd
a Department of Dermatology, Hospital Lluís Alcanyís, Xátiva, Valencia, Spain
b Department of Dermatology, Hospital Sant Joan de Deu, Barcelona, Spain
c Department of Dermatology, University General Hospital, Alicante, Spain
d Department of Dermatology, Hospital Virgen de los Lirios, Alcoy, Alicante, Spain
Related content
F.J. Melgosa-Ramos, A. Vicente Villa, I. Betlloch Mas, S. Santos-Alarcón

Article

This article is available in English

Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial

F.J. Melgosa-Ramos, A. Vicente Villa, I. Betlloch Mas, S. Santos-Alarcón
10.1016/j.ad.2024.08.010
Actas Dermosifiliogr. 2025;116:439-41
Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?